Specific ways we can assist your venture/angel investment firm with potential and/or existing life science company investments and add value include:

• Research, Product, and Commercialization Strategy guidance for your portfolio companies, covering all aspects of R&D and product/service development and commercialization strategy, optimization, implementation, and execution.
• Provide strategic guidance to your portfolio clients on business options to unforeseen dominant I.P. issues (e.g. previously unknown I.P. rights that come to the surface and are asserted against a portfolio company may require a preliminary evaluation of the asserted rights coupled with strategic thinking on business options to responding to and circumnavigating the potential threat).
• Assist in early (pre-formal due diligence) assessments of the proposed I.P. strategies and stated I.P. assets of companies that are potential portfolio investments for your firm.
• Provide executive-level “Intellectual Property Asset Essentials” type programs offered to executive-level managers at your portfolio companies. These programs, covering a pre-set range of essential I.P. topics highly relevant to business growth, are designed to efficiently arm corporate executives with what they need to know about effectively building, managing, and optimally leveraging their company’s I.P. assets to maximize return-on-investment.

In providing these services, we may work along side other business and/or strategic/market consultants being utilized by investors and/or their portfolio companies.

The seminars we offer are useful for executives in all technology sectors, and are not limited to the biotechnology/life sciences sector.